Barbara Sharp Barbara Sharp, 66, passed away peacefully at her home in Santa Barbara on Tuesday, Jan. 13, 2026, after living ...
About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a life sciences company developing precision genetic ...
Larimar Therapeutics is deeply undervalued, trading at ~$3.40 despite a de-risked safety profile and a clear regulatory path ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...
Highly Pathogenic Avian Influenza continues to infect birds and mammals across the U.S. and Canada, including New York State.
SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected ...
Though avian influenza poses a fairly low risk to the public, it's highly contagious between birds and can even spread to ...
This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.
As of Tuesday, January 13, Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 5.36%, which has investors questioning ...
LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...
The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results